European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion for BYOOVIZ® (ranibizumab) pre-filled syringe (PFS) PFS presentation to become available in Europe in the second quarter of 2026, after the full transition of commercial rights from Biogen back to Samsung Bioepis in January 2026 INCHEON, Korea–(BUSINESS WIRE)–#amd–Samsung Bioepis Co., … [Read more…]

Company continues to advance multi-pronged strategy to significantly contain the litigation by the end of 2026 LEVERKUSEN, Germany–(BUSINESS WIRE)–Bayer is pleased the Solicitor General supports U. S. Supreme Court review of the petition for a writ of certiorari in the Durnell case and agrees with the company’s arguments on preemption. The company believes that the … [Read more…]

VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Alpha Cognition will participate in an upcoming virtual fireside chat hosted by Boris Peaker of Titan Partners. The discussion will focus on commercialization efforts and research … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Competitor Analysis: PSMA-Targeted Therapy & Radiodiagnostics” report has been added to ResearchAndMarkets.com’s offering. This competitive intelligence report about PSMA-Targeted Therapies & Radiodiagnostics provides a competitor evaluation in the field of product candidates in research and development targeting prostate-specific membrane antigen (PSMA). The report lists PSMA-targeted R&D programs by R&D phase in a tabular … [Read more…]

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced a merger with MindWave Innovations Inc, uniting Apimeds’ late-stage, non-opioid pain-management biologic portfolio with MindWave’s AI-driven Bitcoin treasury, digital asset yield generation, and $NILA-powered ecosystem. The combined company integrates high-growth biotechnology and institutional digital-treasury capabilities, with the merger supported by a simultaneous PIPE of up to $100 … [Read more…]

BAAR, Switzerland–(BUSINESS WIRE)–$NVCR–Novocure (NASDAQ: NVCR) today announced the appointment of Frank Leonard as Chief Executive Officer (CEO), effective immediately. Mr. Leonard previously served as President of Novocure and succeeds Ashley Cordova who has resigned from the company. “During his more than 15-year career at Novocure, Frank has led many of our global business operations developing … [Read more…]

LUBLIN, Poland–(BUSINESS WIRE)–#HIVawareness–On the occasion of World AIDS Day 2025, AHF Poland reminds the public that the fight to end the HIV/AIDS epidemic is far from over. Every year, the world records as many as 1.3 million new HIV infections, a clear signal that we cannot afford to become complacent. Now is the time to … [Read more…]

The company will showcase a wave of transformative innovations designed to address the most pressing challenges in healthcare, spanning the care journey across smart devices and drugs throughout disease states enabled by cloud and AI solutions. GE HealthCare has invested more than $3B in R&D since 2022, delivering an innovation renaissance across disease states to … [Read more…]

SIGNA Bolt1, a new 3T MRI scanner, is designed with a next-gen gradient system engineered to support precision diagnostics, clinical efficiency, and advanced research capability. SIGNA Sprint with Freelium,2 a new sealed magnet MRI system, seeks to reimagine 1.5T MRI by combining a sustainable design with remarkable image quality, and operational autonomy to expand access … [Read more…]

LONDON–(BUSINESS WIRE)–#AIDS–In honour of World AIDS Day 2025, AIDS Healthcare Foundation (AHF) UK will host two community events to emphasize that the work to end HIV/AIDS is not over. The first commemoration will take place on Monday, 1 December, at the Croydon BME Forum Wellness Centre in the Whitgift Shopping Centre (1st Floor, CR0 1LP), … [Read more…]